NGONGA NANA: Open Payments
NPI 1740859743 · MORRISONVILLE, NY. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,679 in 67 payments from 12 companies in 2025. Trend: 2023 $669 · 2024 $863 · 2025 $1,679
Food & beverage: $1,562Education: $117
| Company | Payments | Amount |
|---|---|---|
| Supernus Pharmaceuticals, Inc. | 5 | $395 |
| Janssen Pharmaceuticals, Inc | 15 | $260 |
| Teva Pharmaceuticals USA, Inc. | 7 | $224 |
| Neurocrine BioSciences, Inc. | 6 | $169 |
| Alkermes, Inc. | 7 | $159 |
| Otsuka America Pharmaceutical, Inc. | 12 | $156 |
| ABBVIE INC. | 4 | $103 |
| E.R. Squibb & Sons, L.L.C. | 5 | $93 |
| Lundbeck LLC | 2 | $42 |
| Axsome Therapeutics, Inc. | 2 | $34 |
Products named: Qelbree, INGREZZA, SPRAVATO, INVEGA SUSTENNA, ABILIFY ASIMTUFII, VRAYLAR, COBENFY, REXULTI.
Industry payments across NY — which companies pay providers there.
